Results 111 to 120 of about 5,584 (128)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Anthony C Gordon, Paul Mouncey, Farah Al-Beidh   +2 more
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, Peter Willeit, Pei Gao
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

New England Journal of Medicine, 2007
Allan Vaag, Burkhardt Seifert, Thomas Mandrup-Poulsen   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly  

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

New England Journal of Medicine, 2012
Ka Papp, Alan Menter, James G Krueger
exaly  

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

Nature, 1984
Warren J Leonard, Thomas A Waldmann
exaly  

The Interleukin-2 Receptor γ Chain: Its Role in the Multiple Cytokine Receptor Complexes and T Cell Development in XSCID

Annual Review of Immunology, 1996
Motonari Kondo, Nobuyuki Tanaka, Naoto Ishii   +2 more
exaly